Patent details

EP2592156 Title: Gene expression markers of tumor resistance to HER2 inhibitor treatment

Basic Information

Publication number:
EP2592156
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP121941033
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Gene expression markers of tumor resistance to HER2 inhibitor treatment
French Title of Invention:
Marqueurs d'expression de gène de résistance tumorale à un traitement par inhibiteur HER2
German Title of Invention:
Genexpressionsmarker für Tumorresistenz gegen Behandlung mit HER2-Inhibitor
SPC Number:

Dates

Filing date:
04/06/2008
Grant date:
20/04/2016
EP Publication Date:
20/04/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/05/2013
EP B1 Publication Date:
20/04/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/06/2016
Expiration date:
04/06/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/06/2008
 
 

Name:
Genentech Inc.
Address:
1 DNA Way, South San Francisco, CA 94080, United States (US)

Inventor

1

Name:
Stern Howard
Address:
United States (US)

2

Name:
Lee-Hoeflich Si Tuen
Address:
United States (US)

Priority

Priority Number:
942906 P
Priority Date:
08/06/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
C12Q 1/68;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages